1. 22nd Century Group, Inc.

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. 22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors

      22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors
      WILLIAMSVILLE, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (22nd Century or the Company), a leading plant-based, life science company driven by next generation plant biotechnology, today announced the appointment of Michael Koganov, Sc.D., Ph.D., to its Board of Directors...
      Read Full Article
    3. 22nd Century Group Appoints New Director and New Chairman

      22nd Century Group Appoints New Director and New Chairman
      Williamsville, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, announced the appointment of Roger OBrien as a new member of 22nd Century Groups Board of Directors (the Board) and the appointment of Nora Sullivan, an existing director of the Board, as the new ...
      Read Full Article
    4. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content